Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BRVEBraveheart Bio, Inc.

Nasdaq · CIK 0002131524
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts141

Identity from submissions API

NameBraveheart Bio, Inc.
CIK0002131524
TickersBRVE
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN992981994
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(415) 707-6312
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
ONE LETTERMAN DR.
BLDG. A, STE. A4-300
SAN FRANCISCO
CA
94129
CA
Mailing address
ONE LETTERMAN DR.
BLDG. A, STE. A4-300
SAN FRANCISCO
CA
94129
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

53 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001628280-26-074219 005-95888 261561969 34 7807
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-462144 005-95888 261555485 34 11809
2026-11-10 10-Q 10-Q 0001628280-26-072709 001-43432 261540316 34 7046694 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001628280-26-072702 001-43432 261540236 34 340146 1 1
2026-11-09 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-124063 005-95888 261533615 34 7347
2026-11-06 8-K 8-K 7.01,9.01 0001628280-26-071586 001-43432 261531464 34 302504 1 1
2026-11-05 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002715 005-95888 261526119 34 11647
2026-09-10 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000947871-26-000860 005-95888 261371906 34 33533
2026-09-08 10-Q 10-Q 0001628280-26-060905 001-43432 261365128 34 6197181 1 1
2026-09-08 8-K 8-K 2.02,9.01 0001628280-26-060904 001-43432 261365114 34 367400 1 1
2026-08-18 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0000947871-26-000814 005-95888 261291714 34 34418
2026-08-14 3 xslF345X06/form3-08142026_090827.xml 0002003663-26-000005 5414
2026-08-14 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001889476-26-000004 005-95888 261283241 34 38180
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001231919-26-000910 005-95888 261282283 34 30051
2026-08-11 4 xslF345X06/form4-08112026_090855.xml 0001231919-26-000859 15564
2026-08-11 4 xslF345X06/ownership.xml 0000947871-26-000783 13334
2026-08-11 4 xslF345X06/ownership.xml 0000947871-26-000782 17211
2026-08-10 4 OWNERSHIP DOCUMENT 0001104659-26-093140 8243
2026-08-07 4 4 0001193125-26-340528 21384
2026-08-07 4 FORM 4 0001470831-26-000804 8969
2026-08-07 4 FORM 4 0001470831-26-000803 5583
2026-08-07 4 FORM 4 0001470831-26-000802 6032
2026-08-07 4 FORM 4 0001470831-26-000801 8186
2026-08-07 4 FORM 4 0001470831-26-000800 8898
2026-08-07 4 FORM 4 0001470831-26-000799 7026
2026-08-07 4 FORM 4 0001470831-26-000798 9707
2026-08-07 4 FORM 4 0001470831-26-000797 5624
2026-08-07 4 FORM 4 0001470831-26-000796 6987
2026-08-07 8-K 8-K 5.03,9.01 0001628280-26-054842 001-43432 261254163 34 221223
2026-08-06 S-8 S-8 0001628280-26-054371 333-298060 261249579 33 252111 1 1
2026-08-06 424B4 S-1/A 0001628280-26-054354 333-297456 261249440 33 12251150
2026-08-06 CERT BRVE_8A_Cert_2131524.pdf 0001354457-26-000761 001-43432 261246205 34 181044
2026-08-06 3 OWNERSHIP DOCUMENT 0001104659-26-091481 5545
2026-08-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002550 333-297456 261245641 33 1778
2026-08-05 3 xslF345X06/ownership.xml 0000947871-26-000749 9101
2026-08-05 3 xslF345X06/form3-08062026_010811.xml 0001231919-26-000833 21765
2026-08-05 3 3 0001193125-26-336143 14740
2026-08-05 3 FORM 3 0001470831-26-000780 10005
2026-08-05 3 FORM 3 0001470831-26-000779 9265
2026-08-05 3 FORM 3 0001470831-26-000778 7455
2026-08-05 3 FORM 3 0001470831-26-000777 7492
2026-08-05 3 FORM 3 0001470831-26-000776 9532
2026-08-05 3 FORM 3 0001470831-26-000775 11463
2026-08-05 3 FORM 3 0001470831-26-000774 10767
2026-08-05 3 FORM 3 0001470831-26-000773 7414
2026-08-05 3 FORM 3 0001470831-26-000772 9950
2026-08-05 3 FORM 3 0001470831-26-000771 10288
2026-08-05 S-1MEF S-1MEF 0001628280-26-053690 333-298034 261245447 33 213133 1 1
2026-08-03 8-A12B 8-A12B 0001628280-26-051795 001-43432 261232717 34 20379
2026-07-30 S-1/A S-1/A 0001628280-26-050756 333-297456 261219982 33 14335834 1 1
2026-07-15 S-1 S-1 0001628280-26-048213 333-297456 261175297 33 14518200 1 1
2026-06-08 DRS/A filename1.htm 0001628279-26-000717 377-09309 261073622 33 12518362
2026-04-29 DRS filename1.htm 0001628279-26-000549 377-09309 26917440 33 11902784

Latest XBRL company facts

One latest value per concept from companyfacts (141 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 89.87M 2026-11-06 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
ffd NetFeeAmt NetFeeAmt USD 32,304.79 2026-08-06 S-8 2026-08-06 0001628280-26-054371
ffd TtlFeeAmt TtlFeeAmt USD 32,304.79 2026-08-06 S-8 2026-08-06 0001628280-26-054371
ffd TtlOfferingAmt TtlOfferingAmt USD 233.92M 2026-08-06 S-8 2026-08-06 0001628280-26-054371
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-06 S-8 2026-08-06 0001628280-26-054371
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-05 S-1MEF 2026-08-05 0001628280-26-053690
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 8.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 732,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -718,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 620.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD 3.62M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.79M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 35.50M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 13.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap Assets Assets USD 514.45M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap AssetsCurrent Assets, Current USD 359.57M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 501.46M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 121.29M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 503.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 121.29M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 32.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 14.20M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 89.87M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 82.07M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap CommonStockValue Common Stock, Value, Issued USD 8,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -56.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 213.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent USD 228.26M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent USD 154.68M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterest DebtSecuritiesAvailableForSaleExcludingAccruedInterest USD 382.23M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent USD 227.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent USD 154.25M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense USD 6.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 2.81M 2026-06-30 2026 Q2 10-Q 2026-09-08 0001628280-26-060905
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.66 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.66 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.62M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 45.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 21.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 7.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 28,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 10.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 1.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap InvestmentIncomeAmortizationOfDiscount Investment Income, Amortization of Discount USD 496,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 5.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.077 2026-01-31 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 538,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 433,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 105,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 23,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap Liabilities Liabilities USD 16.85M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 514.45M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap LiabilitiesCurrent Liabilities, Current USD 16.67M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 464.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -385.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -46.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -55.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -59.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -59.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 5.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OperatingExpenses Operating Expenses USD 61.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -61.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 515,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 415,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OperatingLeasePayments Operating Lease, Payments USD 400,000 2026-01-01 2026-01-31 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 510,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 30,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 98,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -718,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 6.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 75,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 3,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-09-08 0001628280-26-060905
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -55,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 4.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 382.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PaymentsToAcquireLongtermInvestments Payments to Acquire Long-term Investments USD 154.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 28,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 227.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 49.66M 2026-06-30 2026 Q2 10-Q 2026-09-08 0001628280-26-060905
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 10.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 409.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 59.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 20,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap RedeemablePreferredStockDividends Redeemable Preferred Stock Dividends USD 3.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff Research and Development Asset Acquired Other than Through Business Combination, Written-off USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 39.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -122.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 795,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 5.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 433,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 107,397 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 16.17 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 213,230 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 5.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.56 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 48.23M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.68M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 12.13 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 10,702 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 1.71 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 12.43 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 497.60M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.228 2026-07-29 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap StockIssued1 Stock Issued USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 49.66M 2026-08-06 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 213.52M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 404.41M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 1,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 217.50M 2026-06-30 2026 Q2 10-Q 2026-09-08 0001628280-26-060905
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 1 2026-04-24 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 217.50M 2026-06-30 2026 Q2 10-Q 2026-09-08 0001628280-26-060905
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 217.50M 2026-06-30 2026 Q2 10-Q 2026-09-08 0001628280-26-060905
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 60.00M 2026-04-24 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 22.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 8.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 30.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 22.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001628280-26-072709

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →